SCHEMBL939482

SCHEMBL939482

COc1cc(C)c(C(=O)Cl)c(C)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.56
HPGD P15428 2/20 0.56
POLB P06746 3/20 0.49
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.42
TSHR P16473 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPK1 P28482 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
G6PD P11413 1/20 0.41
RECQL P46063 1/20 0.41
MCL1 Q07820 1/20 0.41
USP2 O75604 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HTT P42858 1/20 0.39
LMNA P02545 1/20 0.37
ACHE P22303 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9956291 0.88 CYP3A4 (0.51) CYP3A4HPGDPOLBKMT2AMEN1
SCHEMBL484746 0.84 KMT2A (0.64) CYP3A4HPGDPOLBKMT2AMEN1
Hydrochloric Acid SCHEMBL939484 0.83 KMT2A (0.62) CYP3A4HPGDPOLBKMT2AMEN1
SCHEMBL2383124 0.80 CYP3A4 (0.58) CYP3A4HPGDPOLBKMT2AMEN1
SCHEMBL7123880 0.78 CYP3A4 (0.56) CYP3A4HPGDPOLBKMT2AMEN1
SCHEMBL9713491 0.78 CYP3A4 (0.58) CYP3A4HPGDKMT2AMEN1ALDH1A1
SCHEMBL11816616 0.78 ALDH1A1 (0.46) CYP3A4HPGDKMT2AALDH1A1MAPK1
SCHEMBL11067587 0.78 CYP3A4 (0.79) CYP3A4HPGDPOLBKMT2AMEN1
SCHEMBL17292665 0.78 CYP3A4 (0.36) CYP3A4HPGDPOLBKMT2AMEN1
SCHEMBL1759022 0.77 TAAR1 (0.42) CYP3A4HPGDALDH1A1MAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440542-B1 Substituted benzimidazoles, benzonthiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2013-12-18 EP disclosed
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 US disclosed
EP-2440542-A1 SUBSTITUTED BENZIMIDAZOLES, BENZOTHIAZOLES AND BENZOXAZOLES Grünenthal GmbH (DE) 2012-04-18 EP disclosed
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles GRUENENTHAL GMBH (DE) 2011-01-13 US disclosed
WO-2010142402-A1 SUBSTITUTED BENZIMIDAZOLES, BENZOTHIAZOLES AND BENZOXAZOLES Grünenthal GmbH (DE) 2010-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles BDKRB1, BDKRB2, BRD1 CYP3A4 253/4885HPGD 1251/4885POLB 3273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.